Vimarsana
Biggest News Aggregation in the World

Page 2 - Future Framework News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Future Framework. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Future Framework Today - Breaking & Trending Today

UTSA's Lisa Jasinski named 2023-24 Fellow for The Society for College and University Planning | UTSA Today | UTSA - Vimarsana News

UTSA's Lisa Jasinski named 2023-24 Fellow for The Society for College and University Planning | UTSA Today | UTSA

Utsa.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from utsa.edu Daily Mail and Mail on Sunday newspapers.

Source: utsa.edu
Another Pfizer exec admits "we flew the aeroplane while we were still building it", evidencing mRNA shots were prematurely released - Vimarsana News

Another Pfizer exec admits "we flew the aeroplane while we were still building it", evidencing mRNA shots were prematurely released

An admission by recently retired Pfizer exec Kathrin Jansen proves that its mRNA Covid-19 vaccines were pushed to market before being tested.

SKIP THE SCIENCE: FDA allows rollout of UNTESTED Big Pharma COVID shots - Vimarsana News

SKIP THE SCIENCE: FDA allows rollout of UNTESTED Big Pharma COVID shots

The Food and Drug Administration (FDA) adopted back in June a "Future Framework" scheme that allows Pfizer and Moderna to reformulate and release updated Wuhan coronavirus (COVID-19) [...]

How Pfizer Profited From the Pandemic - Vimarsana News

How Pfizer Profited From the Pandemic

Not only has pandemic doubled Pfizer’s annual revenue, it has also given the drugmaker unique weight in determining U.S. health policy — something that concerns even staunch vaccine-pushers like Dr. Paul Offit

How Pfizer profited from the pandemic - Vimarsana News

How Pfizer profited from the pandemic

STORY AT-A-GLANCE The COVID-19 pandemic has been a real boon to Pfizer. Not only has it doubled Pfizer’s annual revenue, it has also given the drugmaker unique weight in determining U.S. health [...]